WA
TEVA icon

WealthTrust Axiom’s Teva Pharmaceuticals TEVA Stock Holding History

WealthTrust Axiom’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-13,386
Closed -$100K – 255
2022
Q2 		$100K Buy
13,386
+2
+0% +$17 0.04% 224
2022
Q1 		$125K Hold
13,384
– – 0.04% 241
2021
Q4 		$107K Buy
13,384
+1,000
+8% +$9.03K 0.03% 239
2021
Q3 		$120K Sell
12,384
-143
-1% -$1.34K 0.04% 231
2021
Q2 		$124K Hold
12,527
– – 0.04% 246
2021
Q1 		$144K Buy
12,527
+2,387
+24% +$27.4K 0.05% 225
2020
Q4 		$97K Sell
10,140
-5,044
-33% -$48.3K 0.04% 219
2020
Q3 		$136K Hold
15,184
– – 0.06% 186
2020
Q2 		$187K Buy
15,184
+1,500
+11% +$17K 0.08% 174
2020
Q1 		$122K Buy
13,684
+1,573
+13% +$16.1K 0.06% 166
2019
Q4 		$118K Sell
12,111
-938
-7% -$8.37K 0.04% 206
2019
Q3 		$89K Hold
13,049
– – 0.03% 217
2019
Q2 		$120K Buy
13,049
+1,700
+15% +$20.5K 0.04% 212
2019
Q1 		$177K Sell
11,349
-412
-4% -$7.27K 0.06% 207
2018
Q4 		$181K Sell
11,761
-145
-1% -$2.97K 0.07% 189
2018
Q3 		$256K Hold
11,906
– – 0.09% 181
2018
Q2 		$289K Buy
11,906
+150
+1% +$3.06K 0.1% 169
2018
Q1 		$200K Sell
11,756
-3,192
-21% -$62.3K 0.07% 205
2017
Q4 		$283K Buy
14,948
+3,440
+30% +$51.7K 0.11% 167
2017
Q3 		$202K Buy
11,508
+1,895
+20% +$42.6K 0.08% 194
2017
Q2 		$319K Buy
+9,613
New +$298K 0.12% 149

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

WealthTrust Axiom's TEVA Position: Q3 2022 in Review

WealthTrust Axiom sold out of Teva Pharmaceuticals (TEVA) in Q3 2022, closing a stake of 13,386 shares — an estimated $100K sold.

WealthTrust Axiom first reported a position in TEVA in Q2 2017 and held it in 21 quarters. The position peaked at $319K in Q2 2017. 430 funds tracked by Wall St. Rank hold TEVA as of Q3 2022.

  • WealthTrust Axiom reported no remaining Teva Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • WealthTrust Axiom sold 13,386 Teva Pharmaceuticals shares in Q3 2022, an estimated $100K.
  • WealthTrust Axiom first reported a position in Teva Pharmaceuticals in Q2 2017 and held it in 21 quarters.
  • WealthTrust Axiom's Teva Pharmaceuticals position peaked at $319K in Q2 2017.
  • 430 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2022.

Based on WealthTrust Axiom's 13F filing for Q3 2022, filed 3 Nov 2022.